Compared with placebo, olanzapine significantly improves nausea prevention in patients treated with emetogenic chemotherapy, according to a study in The New England Journal of Medicine. Read more
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.
